February, 2024
February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines
Jan 16, 2024, 05:48

Stephen V Liu: Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines

Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Lombardi Comprehensive Cancer Center, posted on X/Twitter:

“Many updates in the 1.2024 National Comprehensive Cancer Network (NCCN) NSCLC guidelines including:
– amivantamab + carbo/pem preferred 1L for EGFR exon 20 (PAPILLON)
– amivantamab + carbo/pem for
EGFR post osimertinib (MARIPOSA2)
– repotrectinib for 1L
ROS1 (TRIDENT)
– atezolizumab monotherapy for PS3 (IPSOS).”

Source: Stephen V Liu/X